Hematopoietic stem cell transplantation is a life-saving therapy for many patients with
cancer, as well as patients with some nonmalignant hematologic disorders, such as aplastic …

Hematopoietic cell transplantation is becoming an increasingly common treatment modality
for a variety of diseases. However, patient survival may be limited by substantial treatment …

Hematopoietic stem cell transplant (HSCT) patients are at risk for acute kidney disease and
CKD, which confer excess morbidity and mortality in this patient population. A main cause of …

Results Incidence of AKI by day 100 was 64%. Exposure to tacrolimus and other
nephrotoxins conferred a higher risk of AKI, but tacrolimus levels were not associated with …

Acute kidney injury (AKI) increases early mortality in allogeneic hematopoietic cell transplant
(allo-HCT) recipients and may accelerate chronic kidney disease (CKD) development. We …

Acute kidney injury in hematopoietic stem cell transplantati... : Current Opinion in Critical Care
Acute kidney injury in hematopoietic stem cell transplantation : Current Opinion in Critical …

Background While acute kidney injury (AKI) is commonly reported following hematopoietic
stem cell transplant (HCT), the incidence and impact of AKI on mortality among patients …

Hematopoietic stem cell transplantation (HSCT) is a highly effective treatment strategy for
lymphoproliferative disorders and bone marrow failure states including aplastic anemia and …

Background Previous reports have shown that acute kidney injury (AKI) is common after
hematopoietic stem cell transplantation (HSCT), which is a crucial treatment for patients with …

Acute kidney injury (AKI) following stem-cell transplantation (SCT) contributes to a poor
prognosis, yet its impact may vary depending on the timing of AKI onset. A prospective …